Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Tampa, Fla., Sept. 01, 2023 (GLOBE NEWSWIRE) -- UMA Education, Inc., (UMA), the organization that operates Ultimate Medical Academy, a non-profit higher education institution with the mission of...
-
VICTORIA, SEYCHELLES, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bitget, top crypto derivatives and copy trading platform, announces the launch of the Bitget Builders Program as its latest initiative of the...
-
New York, NY, June 07, 2023 (GLOBE NEWSWIRE) -- Known around the globe for its intensive hands-on programs in the art of film, media, and performance, the New York Film Academy (NYFA) is now headed...
-
Washington, DC, May 22, 2023 (GLOBE NEWSWIRE) -- A color-changing lizard, a thick-thumbed bat, a poisonous snake named after a Chinese mythological goddess, an orchid that looks like a muppet, and a...
-
ICG Enterprise Trust plcPreliminary Results for the twelve months ended 31 January 202311 May 2023 Delivering defensive growth Highlights NAV per Share of 1,903p at 31 January 2023...
-
WINTER PARK, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) today announced its operating results and earnings for the quarter...
-
Dover, Delaware, April 17, 2023 (GLOBE NEWSWIRE) -- Investors Academy, a leading online investment platform, is thrilled to announce the launch of Copytrading, a revolutionary feature that is set to...
-
8 March 2023 Admiral Group plc reports resilient 2022 full year results against a backdrop of high inflation 2022 Results Highlights 202220212019% change vs. 2021% change vs. 2019 Group...
-
WINTER PARK, Fla., Feb. 23, 2023 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced its operating results and earnings for the quarter and year ended...
-
MELBOURNE, Australia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...